Abstract Phytochemicals: a class of phytobiotics that plays an important role in the prevention and treatment of digestive and degenerative diseases. These bioactive and pharmacologically active compounds are mainly found as flavonoids, alkaloids, terpenoids, phenolics, and glycosides, and they produce their effects via diverse mechanisms, such as antioxidant properties, anti-inflammatory responses, modulation of metabolic and signaling pathways, and regulation of gene expression. The fact that they can hit multiple molecular targets makes them a good fit for treating complex diseases like cancer, cardiovascular disease, diabetes mellitus and neurodegenerative disease. The extensive review below describes the mechanistic roles of the major classes of phytochemicals associated with health benefits and disease prevention. This narrative additionally includes recent structural biological aspects disclosing the molecular basis of their action on important cellular targets, as well as their pharmacokinetic features established in pre-clinical experimental settings. Especially strategies involving nanoformulations are investigated as perspective tools to address native restrictions linked to solubility, stability, and bioavailability towards improving therapeutic activity. Emerging data from recent clinical trials, highlight the effectiveness and safety profiles of phytochemicals such as curcumin, resveratrol, quercetin, epigallocatechin gallate (EGCG), and berberine in human populations. These studies suggest that phytochemicals may have potential use or application as adjunct or alternative therapies in metabolic syndrome, inflammation, cancer chemoprevention, and cognitive health. Nevertheless, there remain challenges that prevent the broader adoption of phytochemicals in contemporary therapeutic paradigms. These challenges include variability in phytochemical content arising from environmental variability, limited large-scale clinical validation, a lack of standardisation between formulations, and regulatory complexity. The prospects of phytochemical in therapeutics are bright and research in this area will lead to new findings. It is expected that the emerging concepts of nanotechnology, omics-based personalized medicine, and combinatorial phytopharmaceutical approaches will unveil new translational potentials. Translational success for phytochemical-based interventions will require multidisciplinary collaborations, regulatory harmonization, and increased investment in clinical research. Therefore, phytochemicals are an innovative targeted validated strategy for preventive medicine and health promotion. Incorporating NFLs into mainstream medicine and public health approaches provides promising avenues for alleviating chronic disease burden and promoting wholistic health. Keywords: Phytochemicals, Disease Prevention, Flavonoids, Antioxidants, Cancer, Cardiovascular Disease, Nano-formulation